Basic FGF augments hypoxia induced HIF-1-alpha expression and VEGF release in T47D breast cancer cells
Basic FGF augments hypoxia induced HIF-1-alpha expression and VEGF release in T47D breast cancer cells
复制标题
碱性 FGF 增强 T47D 乳腺癌细胞缺氧诱导的 HIF-1-α 表达和 VEGF 释放
DOI:
10.1080/00313020701444549
复制
发表时间:
2007-08-01
期刊:
影响因子:
4.5
通讯作者:
Fang, Wei-Gang
中科院分区:
文献类型:
--
作者:
Shi, Yong-Hong;Bingle, Lynne;Fang, Wei-Gang
Aim: Both hypoxia inducible factor 1 (HIF-1) and basic fibroblast growth factor (bFGF) play important roles in tumour angiogenesis. This study was designed to clarify the cooperative effect of these two mediators in induction of vascular endothelial cell growth factor (VEGF) release from breast cancer and probe possible mechanisms involved.Methods: Release of VEGF from a breast cancer cell line (T47D) was quantitated by enzyme linked immunosorbent assay (ELISA). Expression of HIF-1 and ERK was assayed using Western blotting. Transient transfection and dual luciferase reporter assay were used to study HIF-1 transactivity.Results: The data showed that hypoxia induced the expression of HIF-1 alpha protein, the transactivity of HIF-1 and the release of VEGF. bFGF further augmented these hypoxic inductions. The PI3K pathway was required for these processes as demonstrated by application of PI3Kinase inhibitor (LY294002) or mutant construct transfections. In contrast, the MEK1 inhibitor PD98059 showed no effect on either activation of HIF-1 or VEGF release, which is in agreement with our finding that ERK1/2 was not activated by hypoxia. Under hypoxic conditions, bFGF activated the MEK1/ERK pathway. PD98059 blocked the activation of ERK1/2 and suppressed bFGF-induced HIF-1 transactivity, yet the protein expression of HIF-1 alpha or VEGF release was not affected by PD98059.Conclusion: bFGF augments hypoxia induced VEGF release mainly through the PI3K pathway and partly depending on HIF-1 activity. Elucidation of this mechanism may provide a new target for anti-angiogenesis in cancer therapy.